Progression of Grafted Bone Density in Cleft Alveolus
Launched by CHANG GUNG MEMORIAL HOSPITAL · Jul 23, 2021
Trial Information
Current as of June 09, 2025
Completed
Keywords
ClinConnect Summary
Patient Information and Data Collection Patients who had nonsyndromic unilateral or bilateral cleft lip and alveolus with or without cleft palate and received ABG at our center between 2016 and 2018 were enrolled. All patients underwent at least 2 CBCT scans after operation. Postoperative image acquisition was performed at two time points, namely 6 months (T1) and 2 years (T2) after ABG. The ABG procedures for all patients were performed by the same senior surgeon per the protocol of our center, which comprises an iliac cancellous bone graft and the sealing of the Scarpa fascia to the defec...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who had nonsyndromic unilateral or bilateral cleft lip and alveolus with or without cleft palate
- • Patients received alveolar bone graft at their 9 years of age
- • Patients received twice CBCT after the surgery
- Exclusion Criteria:
- • Patient had syndromic cleft alveolus
- • Patient underwent two-stage ABG (performed for bilateral cases)
- • Patient exhibited failed grafted tissue
About Chang Gung Memorial Hospital
Chang Gung Memorial Hospital, one of the largest healthcare organizations in Taiwan, is renowned for its commitment to advancing medical research and improving patient care. As a clinical trial sponsor, the hospital leverages its extensive clinical expertise and state-of-the-art facilities to conduct innovative research across various medical disciplines. With a focus on collaboration and ethical practices, Chang Gung Memorial Hospital aims to contribute to the global body of medical knowledge through rigorous clinical trials that enhance treatment options and improve health outcomes for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taoyuan, , Taiwan
Patients applied
Trial Officials
Pangyun Chou, MD
Principal Investigator
Chang Gung Memorial Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials